Compare AHCO & CEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AHCO | CEVA |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2017 | 2002 |
| Metric | AHCO | CEVA |
|---|---|---|
| Price | $10.16 | $46.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $13.50 | ★ $30.33 |
| AVG Volume (30 Days) | ★ 1.1M | 897.0K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,244,857,000.00 | $87,507,000.00 |
| Revenue This Year | $9.00 | $12.37 |
| Revenue Next Year | $6.93 | $13.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.45 |
| 52 Week Low | $8.33 | $17.02 |
| 52 Week High | $13.43 | $51.25 |
| Indicator | AHCO | CEVA |
|---|---|---|
| Relative Strength Index (RSI) | 43.82 | 60.85 |
| Support Level | $9.87 | $19.18 |
| Resistance Level | $10.21 | $51.25 |
| Average True Range (ATR) | 0.31 | 3.79 |
| MACD | 0.07 | -0.48 |
| Stochastic Oscillator | 67.98 | 59.98 |
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived mainly from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems. The company operates in one reportable segment: the licensing of IP to semiconductor companies and electronic equipment manufacturers.